Advances in the management of musculoskeletal tumors in adolescents.
作者信息
Dyment P G
出版信息
Cleve Clin Q. 1975 Winter;42(4):303-8.
PMID:765005
Abstract
摘要
相似文献
1
Advances in the management of musculoskeletal tumors in adolescents.青少年肌肉骨骼肿瘤管理的进展
Cleve Clin Q. 1975 Winter;42(4):303-8.
2
[Drug therapy of malignant tumors of the bone and soft tissues].[骨与软组织恶性肿瘤的药物治疗]
Nihon Seikeigeka Gakkai Zasshi. 1981 Dec;55(12):1729-41.
3
The evolution of chemotherapeutic agents for the treatment of pediatric musculoskeletal malignancies.用于治疗儿童肌肉骨骼恶性肿瘤的化疗药物的演变
Orthop Clin North Am. 1996 Jul;27(3):545-9.
4
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.西南肿瘤协作组与癌症和白血病B组针对晚期骨肉瘤、尤因肉瘤和横纹肌肉瘤成人患者开展的阿霉素、达卡巴嗪、异环磷酰胺及美司钠的II期研究。
Cancer. 1998 Apr 1;82(7):1288-95.
5
Effects of Cytembena in the treatment of malignant musculoskeletal tumours.
Neoplasma. 1971;18(5):473-80.
6
Adjuvant chemotherapy in bone tumours.骨肿瘤的辅助化疗
Ann Chir Gynaecol. 1983;72(6):293-7.
7
[Conservative treatment of primary malignant bone tumors in children. Review of 14 cases].[儿童原发性恶性骨肿瘤的保守治疗。14例病例回顾]
Tunis Med. 1996 Oct;74(10):425-31.
8
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.胰岛素样生长因子-I受体激酶抑制剂NVP-AEW541在肌肉骨骼肿瘤中的抗肿瘤活性
Cancer Res. 2005 May 1;65(9):3868-76. doi: 10.1158/0008-5472.CAN-04-3192.
9
Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.盐酸他司美坦在尤因肉瘤、横纹肌肉瘤、滑膜肉瘤和骨肉瘤中的临床前分析。
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5446-54. doi: 10.1158/1078-0432.CCR-06-2661.
10
[The role of polychemotherapy in the management of malignant bone tumors].[多药联合化疗在恶性骨肿瘤治疗中的作用]
Chirurg. 2002 Dec;73(12):1170-3. doi: 10.1007/s00104-002-0555-9.
Zotero 插件